Geoghegan, E., Dutta, A. K., Niman, S. M., Nadkarni, L., Halfhide-Simpson, R., Wang, N., Lombard, J. M., Ritchie, G., Cuff, K. E., Bae, S., White, M. A., Wilcken, N., Boyle, F. M., Hay, T., Badger, H. D., Francis, P. A., Regan, M. M., Zdenkowski, N., Loi, S., Dawson, S. (2026). CAPTURE: A phase II trial evaluating alpelisib + fulvestrant vs capecitabine in advanced breast cancer patients with
                    <i>PIK3CA</i>
                    -mutant circulating DNA following CDK4/6 inhibition.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.1064